ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,812, issued on Jan. 20, was assigned to TME THERAPEUTICS INC. (Minato-ku, Japan).
"Esophageal stricture suppressing agent" was invented by Hiroyuki Yoneyama (Minato-ku, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel esophageal stricture suppressing agent comprising CHST15 siRNA as an effective ingredient."
The patent was filed on May 8, 2019, under Application No. 17/609,264.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12527812&OS=...